These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. Kitagawa Y, Kunimi K, Ito H, Sato H, Uchibayashi T, Okada Y, Seiki M, Namiki M. J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409 [Abstract] [Full Text] [Related]
24. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR]. Zheng HY, Chen Q, Ye YB, Huang WW. Zhonghua Yi Xue Za Zhi; 2008 Aug 19; 88(32):2267-70. PubMed ID: 19087676 [Abstract] [Full Text] [Related]
27. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues]. Liu R, Pu DM, Cheng YX, Yin L. Zhonghua Yi Xue Za Zhi; 2007 May 22; 87(19):1326-9. PubMed ID: 17727777 [Abstract] [Full Text] [Related]
28. Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer. Luo HZ, Zhou ZG, Yang L, Yu YY, Tian C, Zhou B, Zheng XL, Xia QJ, Li Y, Wang R. Jpn J Clin Oncol; 2005 Dec 22; 35(12):739-44. PubMed ID: 16314344 [Abstract] [Full Text] [Related]
31. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC, Wang F, Elliott RL, Head JF. Anticancer Res; 2001 Dec 22; 21(1B):541-9. PubMed ID: 11299801 [Abstract] [Full Text] [Related]
34. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K. Anticancer Res; 2006 Dec 22; 26(6C):4985-90. PubMed ID: 17214375 [Abstract] [Full Text] [Related]
35. Clinical significance of MT1-MMP mRNA expression in breast cancer. Mimori K, Ueo H, Shirasaka C, Mori M. Oncol Rep; 2001 Dec 22; 8(2):401-3. PubMed ID: 11182063 [Abstract] [Full Text] [Related]
36. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. Sasaki H, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y. J Surg Res; 2001 Dec 22; 101(2):242-7. PubMed ID: 11735282 [Abstract] [Full Text] [Related]
37. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material. Haupt LM, Irving RE, Weinstein SR, Irving MG, Griffiths LR. Mol Cell Probes; 2008 Apr 22; 22(2):83-9. PubMed ID: 17669621 [Abstract] [Full Text] [Related]
38. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Muñoz-Nájar UM, Neurath KM, Vumbaca F, Claffey KP. Oncogene; 2006 Apr 13; 25(16):2379-92. PubMed ID: 16369494 [Abstract] [Full Text] [Related]
39. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]. Gao GL, Liu LD, Zou XS, Chen WX. Zhonghua Fu Chan Ke Za Zhi; 2007 Jan 13; 42(1):34-8. PubMed ID: 17331419 [Abstract] [Full Text] [Related]
40. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours. Wang Y, Xu HT, Ueda Y, Shimasaki M, Wang EH. Pathology; 2007 Oct 13; 39(5):486-90. PubMed ID: 17886098 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]